SECTION I - INFECTIOUS AGENT

NAME: Psittacosis

SYNONYM OR CROSS REFERENCE: Chlamydia psittaci, Ornithosis.

CHARACTERISTICS: Gram positive rickettsial bacteria.

SECTION II - HEALTH HAZARD

PATHOGENICITY: Human: Febrile respiratory tract disease; sudden onset of chills, cough, epistaxis, anorexia, chest pain, splenomegaly, myocarditis, relative bradycardia.

Animals: Diarrhea and pneumonitis in birds, occasionally causing high mortality; drop in egg production in turkeys; abortion in sheep and cattle; conjunctivitus in guinea pigs; pneumonitis in cats.

EPIDEMIOLOGY: Worldwide; major disease problems in psittacines, turkeys, and pigeons in the United States, ducks and geese in Europe; poor sanitation and inadequate ventilation aids spread.

HOST RANGE: Humans, birds, sheep, cattle, cats, and other mammals.

INFECTIOUS DOSE: (Information pending)

MODE OF TRANSMISSION: Inhalation of aerosol agent shed from carrier animal; some human-to-human transmission, usually through saliva; one reported case of a human contracting psittacosis from a cat with pneumonitis.

INCUBATION PERIOD: 4-15 days; usually 10 days.


COMMUNICABILITY: Carrier state in birds may persist for years.

SECTION III - DISSEMINATION

RESERVOIR: Primarily birds.


ZOONOSIS: Yes, from infected birds to humans.
VECTORS: None

SECTION IV - VIABILITY

DRUG SUSCEPTIBILITY: Tetracylines (doxycycline, tetracycline hydrochloride).

SUSCEPTIBILITY TO DISINFECTANTS: 1:1000 dilution of quaternary ammonium compounds is best; 70% isopropyl alcohol, 1% Lysol, 1% sodium hypochlorite (20% commercial bleach), chlorophenols.

PHYSICAL INACTIVATION: Susceptible to heat but resistant to acid and alkaline compounds.

SURVIVAL OUTSIDE HOST: Resistant to drying in feces or nasal discharges.

SECTION V - MEDICAL

SURVEILLANCE: Confirmed by serologic methods in which paired sera are tested for chlamydial antibodies by a complement-fixation test.

FIRST AID/TREATMENT: Treat humans with tetracyclines for 21 days.

IMMUNIZATION: No vaccines for humans.

PROPHYLAXIS: None recommended.

SECTION VI - LABORATORY HAZARDS

LABORATORY-ACQUIRED INNFECTIONS: One of the most commonly reported laboratory-associated bacterial infections.

SOURCES/SPECIMENS: Primary sources are naturally or experimentally infected birds; less important sources are mice and eggs.

PRIMARY HAZARDS: Exposure to infectious aerosols and droplets, created during the handling of infected birds and tissues.

SPECIAL HAZARDS: None

SECTION VII - RECOMMENDED PRECAUTIONS

CONTAINMENT REQUIRENMNTS: BSL-2 practices, containment equipment, and facilities recommended for activities involving necropsy of infected birds and examination of infected tissues and cultures.

PROTECTIVE CLOTIUNG: Gloves during necropsy and during direct skin contact with infected tissues, fluids, etc.; when cleaning cages or handling infected birds wear gloves, protective clothing, surgical masks, and respirator with at least an N95 rating.

OTHER PRECAUTIONS: Wet carcass with detergent and water when performing necropsies to avoid aerosolization of infectious particles and work under hood with exhaust fan.

SECTION VIII - HANDLING INFORMATION

SPELLS: Cover spills with disinfectants listed in Section IV, allowing sufficient contact time (30 minutes) before clean up.

DISPOSAL: Decontaminate all wastes before disposal; autoclave or incinerate wastes.

STORAGE: In sealed containers that are appropriately labeled.

Information provided by the Colorado State University Office of Biosafety- June 16, 1998.

Back to Index